Journal • Tumor mutational burden • PD(L)-1 Biomarker • IO biomarker • Metastases
|
PD-L1 (Programmed death ligand 1) • PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) • TMB (Tumor Mutational Burden) • MET (MET proto-oncogene, receptor tyrosine kinase) • MSI (Microsatellite instability) • TET2 (Tet Methylcytosine Dioxygenase 2) • LRP1B (LDL Receptor Related Protein 1B) • IRS2 (Insulin receptor substrate 2) • PTPRT (Protein tyrosine phosphatase receptor type T) • DOT1L (DOT1 Like Histone Lysine Methyltransferase) • MDC1 (Mediator Of DNA Damage Checkpoint 1)
|
PD-L1 expression • TMB-H • PIK3CA mutation • MET amplification • TET2 mutation • MET mutation • MDC1 mutation